Compare PGEN & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | BLNK |
|---|---|---|
| Founded | 1998 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 86.2M |
| IPO Year | 2013 | 2008 |
| Metric | PGEN | BLNK |
|---|---|---|
| Price | $7.79 | $0.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $8.33 | $2.33 |
| AVG Volume (30 Days) | ★ 3.7M | 1.1M |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.22 |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $230,981,000.00 | $126,197,000.00 |
| Revenue This Year | $1,115.92 | $5.71 |
| Revenue Next Year | $81.04 | $19.65 |
| P/E Ratio | $256.67 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.99 | $0.45 |
| 52 Week High | $8.04 | $2.65 |
| Indicator | PGEN | BLNK |
|---|---|---|
| Relative Strength Index (RSI) | 62.19 | 51.25 |
| Support Level | $6.57 | $0.52 |
| Resistance Level | N/A | $0.62 |
| Average True Range (ATR) | 0.38 | 0.02 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 73.12 | 62.59 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The Blink's principal line of products and services is its Blink EV charging networks, Blink EV charging equipment, and other EV-related services. The Blink Network is a proprietary, cloud-based system that operates, maintains, and manages Blink charging stations and handles the associated charging data, back-end operations, and payment processing. The Blink Network provides fleets, property owners, managers, parking companies, and state and municipal entities, among other types of commercial customers, with cloud-based services.